NORTH CHICAGO, Ill., Jan. 4, 2022 /PRNewswire/ -- AbbVie (NYSE: ABBV) will participate in the 40^th Annual J.P. Morgan Healthcare Conference on Tuesday, January 11, 2022. Members of AbbVie's executive leadership team will present virtually at 2:45 p.m. CT, including Robert A. Michael, vice chairman, finance and commercial operations and chief financial officer, Michael E. Severino, M.D., vice chairman and president, and Jeffrey R. Stewart, executive vice president, chief commercial officer.

A live audio webcast of the presentation will be accessible through AbbVie's Investor Relations website at investors.abbvie.com. An archived edition of the session will be available later that day.

About AbbVie
AbbVie's mission is to discover and deliver innovative medicines that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable impact on people's lives across several key therapeutic areas: immunology, oncology, neuroscience, eye care, virology, women's health and gastroenterology, in addition to products and services across its Allergan Aesthetics portfolio. For more information about AbbVie, please visit us at www.abbvie.com. Follow @abbvie on Twitter, Facebook, Instagram, YouTube and LinkedIn.

View original content:https://www.prnewswire.com/news-releases/abbvie-to-present-at-the-40th-annual-jp-morgan-healthcare-conference-301451930.html

SOURCE AbbVie

Media: Frank Benenati, (224) 688-4169, Frank.Benenati@abbvie.com, Investors: Liz Shea, (847) 935-2211, Liz.Shea@abbvie.com